Work

Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers

Year: 2019
Type: article
Study design: Observational Study
Abstract: BACKGROUND: ) and neurofilament light chain (NFL). Such data proposes that blood is a rich source of potential biomarkers reflecting central nervous system pathophysiology and should be fully explored for biomarkers that show promise in CSF. Recently, soluble fragments of the triggering receptor expressed on myeloid cells 2 (sTREM2) protein in CSF have been reported to be increased in prodromal AD and also in individuals with TREM2 rare genetic variants that increase the likelihood of developing dementia. METHODS: In this study, we measured the levels of plasma sTREM2 and plasma NFL using the MesoScale Discovery and single molecule array platforms, respectively, in 48 confirmed TREM2 rare variant carriers and 49 non-carriers. RESULTS: Our results indicate that there are no changes in plasma sTREM2 and NFL concentrations between TREM2 rare variant carriers and non-carriers. Furthermore, plasma sTREM2 is not different between healthy controls, mild cognitive impairment (MCI) or AD. CONCLUSION: Concentrations of plasma sTREM2 do not mimic the recent changes found in CSF sTREM2.
Language: English
Open Access status: gold
Estimated APC paid: $2,580
OpenAlex ID: W2990955852
FWCI: 1.514
Cites: 61
Cited by: 45
Related to: 10